PharmaResearch Co., Ltd. (KOSDAQ:214450)
552,000
-11,000 (-1.95%)
Oct 17, 2025, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 5.74 trillion as of October 17, 2025. Its market cap has increased by 202.14% in one year.
Market Cap
5.74T
Enterprise Value
5.49T
Revenue
449.81B
Ranking
n/a
PE Ratio
45.09
Stock Price
552,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 5.74T, an increase of 468.25%. That is a compound annual growth rate of 18.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 5,735.09B | 110.29% |
Dec 30, 2024 | 2,727.28B | 144.17% |
Dec 28, 2023 | 1,116.95B | 60.18% |
Dec 29, 2022 | 697.32B | -14.76% |
Dec 30, 2021 | 818.02B | 48.15% |
Dec 30, 2020 | 552.15B | 60.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 80.64T |
Celltrion | 38.77T |
ALTEOGEN | 23.10T |
Yuhan | 8,739.13B |
SK Biopharmaceuticals | 8,050.60B |
Peptron | 5,980.90B |
HLB Co., Ltd. | 5,221.68B |
LigaChem Biosciences | 4,828.21B |